Expression profiles of proliferative and antiapoptotic genes in sporadic and colitis-related mouse colon cancer models

International Journal of Experimental Pathology

Volumn 91, Issue 1, 2010, Pages 44-53

  Švec, Jiří ^a,b   Ergang, Peter ^b   Mandys, Václav ^a   Kment, Milan ^a   Pácha, Jiří ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Colon cancer; Gene expression; Mouse

Indexed keywords

AZOXYMETHANE; CYCLOOXYGENASE 2; DEXTRAN SULFATE; DRINKING WATER; INDUCIBLE NITRIC OXIDE SYNTHASE; INTEGRIN LINKED KINASE; MESSENGER RNA; SURVIVIN; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR TCF 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CARCINOGENESIS; COLITIS; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; DOWN REGULATION; DYSPLASIA; EPITHELIUM CELL; GENE EXPRESSION PROFILING; GENOTOXICITY; LASER MICRODISSECTION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR GENE; UPREGULATION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AZOXYMETHANE; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COLITIS; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; MICE; MICE, INBRED ICR; MICRODISSECTION; MICROTUBULE-ASSOCIATED PROTEINS; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MYB; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TELOMERASE;

EID: 74549178483     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2009.00698.x     Document Type: Article

References (39)

1. Altieri D.C. (2003) Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer 3, 46 54.
2. Ambs S., Miriam W.G., Bennett W.P. et al. (1998) Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 58, 334 341.
3. Arinaga M., Shimizu S., Gotoh K. et al. (2000) Expression of human telomerase subunit genes in primary lung cancer and its clinical significance. Ann. Thorac. Surg. 70, 401 405.
4. Assi K., Mills J., Owen D. et al. (2008) Integrin-linked kinase regulates cell proliferation and tumour growth in murine colitis-associated carcinogenesis. Gut 57, 931 940.
5. Barker N., Morin P.J., Clevers H. (2000) The Yin-Yang of TCF/beta-catenin signaling. Adv. Cancer Res. 77, 1 24.
6. Bissahoyo A., Pearsall R.S., Hanlon K. et al. (2005) Azoxymethane is a genetic background-dependent colorectal tumor initiator and promoter in mice: effects of dose, route, and diet. Toxicol. Sci. 88, 340 345.
7. Bravou V., Klironomos G., Papadaki E., Taraviras S., Varakis J. (2006) ILK over-expression in human colon cancer progression correlates with activation of beta-catenin, down-regulation of E-cadherin and activation of the Akt-FKHR pathway. J. Pathol. 208, 91 99.
8. Choi J., Southworth L.K., Sarin K.Y. et al. (2008) TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLoS Genet. 4, e10.
9. Dedhar S., Williams B., Hannigan G. (1999) Integrin-linked kinase (ILK): a regulator of integrin and growth-factor signalling. Trends Cell Biol. 9, 319 323.
10. Duval A., Rolland S., Tubacher E., Bui H., Thomas G., Hamelin R. (2000) The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines. Cancer Res. 60, 3872 3879.
11. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., DuBois R.N. (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107, 1183 1188.
12. Endo T., Abe S., Seidlar H.B. et al. (2004) Expression of IAP family proteins in colon cancers from patients with different age groups. Cancer Immunol. Immunother. 53, 770 776.
13. Engelhardt M., Drullinsky P., Guillem J., Moore M.A. (1997) Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin. Cancer Res. 3, 1931 1941.
14. Fukutake M., Nakatsugi S., Isoi T. et al. (1998) Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice. Carcinogenesis 19, 1939 1942.
15. Haase M., Gmach C.C., Eke I., Hehlgans S., Baretton G.B., Cordes N. (2008) Expression of integrin-linked kinase is increased in differentiated cells. J. Histochem. Cytochem. 56, 819 829.
16. Hussain S.P. Harris C.C. (2007) Inflammation and cancer: an ancient link with novel potentials. Int. J. Cancer 121, 2373 2380.
17. Itzkowitz S.H. Yio X. (2004) Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G7 G17.
18. Kim H.S., Kundu J.K., Le J.S., Oh T.Y., Na H.K., Surh Y.J. (2008) Chemopreventive effects of the standardized extract (DA-9601) of Artemisia asiatica on azoxymethane-initiated and dextran sulfate sodium-promoted mouse colon carcinogenesis. Nutr. Cancer 60 (Suppl. 1 90 97.
19. Kishimoto Y., Morisawa T., Hosoda A., Shiota G., Kawasaki H., Hasegawa J. (2002) Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane. J. Exp. Clin. Cancer Res. 21, 203 211.
20. Kohno H., Takahashi M., Yasui Y. et al. (2007) A specific inducible nitric oxide synthase inhibitor, ONO-1714 attenuates inflammation-related large bowel carcinogenesis in male Apc(Min/+) mice. Int. J. Cancer 121, 506 513.
21. Marotta A., Parhar K., Owen D., Dedhar S., Salh B. (2003) Characterisation of integrin-linked kinase signalling in sporadic human colon cancer. Br. J. Cancer 88, 1755 1762.
22. Mori F., Piro F.R., Della Rocca C. et al. (2007) Survivin and cyclooxygenase-2 are co-expressed in human and mouse colon carcinoma and in terminally differentiated colonocytes. Histol. Histopathol. 22, 61 77.
23. Narisawa T., Fukaura Y., Terada K., Sekiguchi H. (1999) Inhibitory effects of ursodeoxycholic acid on N-methylnitrosourea-induced colon carcinogenesis and colonic mucosal telomerase activity in F344 rats. J. Exp. Clin. Cancer Res. 18, 259 266.
24. Nowak J., Januszkiewicz D., Lewandowski K. et al. (2003) Activity and expression of human telomerase in normal and malignant cells in gastric and colon cancer patients. Eur. J. Gastroenterol. Hepatol. 15, 75 80.
25. Ohno J., Horio Y., Sekido Y. et al. (2001) Telomerase activation and p53 mutations in urethane-induced A/J mouse lung tumor development. Carcinogenesis 22, 751 756.
26. Oshima M., Dinchuk J.E., Kargman S.L. et al. (1996) Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87, 803 809.
27. Ramsay R.G., Thompson M.A., Hayman J.A., Reid G., Gonda T.J., Whitehead R.H. (1992) Myb expression is higher in malignant human colonic carcinoma and premalignant adenomatous polyps than in normal mucosa. Cell Growth Differ. 3, 723 730.
28. Ramsay R.G., Friend A., Vizantios Y. et al. (2000) Cyclooxygenase-2, a colorectal cancer nonsteroidal anti-inflammatory drug target, is regulated by c-MYB. Cancer Res. 60, 1805 1809.
29. Reya T. Clevers H. (2005) Wnt signalling in stem cells and cancer. Nature 434, 843 850. (Pubitemid 40558990)
30. Rudolph K.L., Chang S., Lee H.W. et al. (1999) Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701 712.
31. Sano H., Kawahito Y., Wilder R.L. et al. (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55, 3785 3789.
32. Sansom O.J., Meniel V.S., Muncan V. et al. (2007) Myc deletion rescues Apc deficiency in the small intestine. Nature 446, 676 679.
33. Seril D.N., Liao J., Yang G.Y. (2007) Colorectal carcinoma development in inducible nitric oxide synthase-deficient mice with dextran sulfate sodium-induced ulcerative colitis. Mol. Carcinog. 46, 341 353.
34. Tanaka T., Kohno H., Suzuki R., Yamada Y., Sugie S., Mori H. (2003) A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci. 94, 965 973.
35. Thompson M.A., Rosenthal M.A., Ellis S.L. et al. (1998) c-Myb down-regulation is associated with human colon cell differentiation, apoptosis, and decreased Bcl-2 expression. Cancer Res. 58, 5168 5175.
36. Wei D., Richardson E.L., Zhu K. et al. (2003) Direct demonstration of negative regulation of tumor growth and metastasis by host-inducible nitric oxide synthase. Cancer Res. 63, 3855 3859.
37. Yan P., Saraga E.P., Bouzourene H., Bosman F.T., Benhattar J. (2001) Expression of telomerase genes correlates with telomerase activity in human colorectal carcinogenesis. J. Pathol. 193, 21 26.
38. Yoshida K., Sugino T., Goodison S. et al. (1997) Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. Br. J. Cancer 75, 548 553. (Pubitemid 27085298)
39. Zhang T., Otevrel T., Gao Z. et al. (2001) Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res. 61, 8664 8667.